Literature DB >> 10705627

Creutzfeldt-Jakob disease in a patient with a lyophilized dura mater graft.

R M Liscić1, V Brinar, P Miklić, B Barsić, J Himbele.   

Abstract

A 37-year-old patient with Creutzfeldt-Jakob disease (CJD) is presented, who had received a cadaveric dura matter graft 12 year before the onset of neurologic symptoms. Initial clinical presentation included cerebellar symptoms, with dementia and myoclonus developing in later stages of the disease. EEG showed diffuse slowing with sporadic triphasic periodic activity. CT was normal in the early stage but pronounced cerebral and cerebellar atrophy with widened sulci were seen on MRI in the late stage of the disease. The prion protein (PrP) gene was homozygous for valin at the polymorphic codon 129. Cerebrospinal fluid analysis for 14-3-3 protein was positive. We believe that this patient is the first Croatian to acquire CJD by dural implant. Based on this case and a review of 66 cases from the literature, it is manifest that the awareness of iatrogenic transmission of CJD and adoption of preventive measures are the only effective way to stop the spread of CJD among surgically treated patients.

Entities:  

Mesh:

Year:  1999        PMID: 10705627

Source DB:  PubMed          Journal:  Acta Med Croatica        ISSN: 1330-0164


  3 in total

Review 1.  Evaluation of current biologic meshes in pelvic organ prolapse repair.

Authors:  Ashley Cox; Sender Herschorn
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

2.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

3.  Decreasing latitude and increasing regulation in transplantable tissue programs.

Authors:  Linda Humphries
Journal:  AORN J       Date:  2005-11       Impact factor: 0.676

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.